18-PUB: The Efficacy and Safety of Oral Antidiabetic Drugs Added to Short-Term CSII in Patients with Type 2 Diabetes

18-PUB: The Efficacy and Safety of Oral Antidiabetic Drugs Added to Short-Term CSII in Patients with Type 2 Diabetes

Objective: Short-term continuous subcutaneous insulin infusion (CSII) has been proved to be efficacy in T2D patients. However, limited evidence is available about the effect of oral anti-diabetic drugs (OADs) added to short-term CSII in T2D. This study is aimed to compare the efficacy of OADs added...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2024-06, Vol.73, p.1
Hauptverfasser: Jiang, Wei, Chen, Danrui, Xu, Wen, Zeng, Longyi
Format: Artikel
Sprache:eng
Schlagworte:
Diabetes
Diabetes mellitus (non-insulin dependent)
Drug dosages
Hypoglycemia
Insulin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: Short-term continuous subcutaneous insulin infusion (CSII) has been proved to be efficacy in T2D patients. However, limited evidence is available about the effect of oral anti-diabetic drugs (OADs) added to short-term CSII in T2D. This study is aimed to compare the efficacy of OADs added to CSII with CSII alone on glucose control and glycemic variability (GV) in T2D. Methods: A total of 206 hospitalized T2D patients who received CSII alone (CSII group, n=78) or CSII plus OADs (+OADs group, n=128) were included. The patient's glycemic control and GV indices were derived from capillary blood glucose (BG) monitoring seven times a day. The insulin doses and time to achieve target BG (FBG
ISSN:0012-1797
1939-327X
DOI:10.2337/db24-18-PUB